tranexamic acid and Lung Neoplasms
tranexamic acid has been researched along with Lung Neoplasms in 10 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Lung Neoplasms: Tumors or cancer of the LUNG.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"The antifibrinolytic action of tranexamic acid (AMCHA) on the growth and metastasis of rabbit V2 carcinoma having high fibrinolytic activity was studied." | 7.66 | Effect of tranexamic acid on the growth and metastasis of V2 carcinoma in rabbits. ( Kodama, Y; Tanaka, K, 1981) |
"Tranexamic acid (TEA) was injected through a 22-gauge Wang cytology needle into the lesion in nominal doses of 250-500 mg." | 5.40 | Bronchoscopic intratumoral injection of tranexamic acid to prevent excessive bleeding during multiple forceps biopsies of lesions with a high risk of bleeding: a prospective case series. ( Zamani, A, 2014) |
"The antifibrinolytic action of tranexamic acid (AMCHA) on the growth and metastasis of rabbit V2 carcinoma having high fibrinolytic activity was studied." | 3.66 | Effect of tranexamic acid on the growth and metastasis of V2 carcinoma in rabbits. ( Kodama, Y; Tanaka, K, 1981) |
"The fibrinolytic inhibitor tranexamic acid affects certain experimental tumours; it prolongs survival (Lewis lung adenocarcinoma), decreases tumour weight (C3H breast carcinoma), and inhibits ascitic production (AH 130 rat hepatoma)." | 3.66 | Effect of tranexamic acid on progress of experimental tumours and on DNA-synthesis. ( Astedt, B; Tropé, C, 1980) |
"Tranexamic acid (TEA) was injected through a 22-gauge Wang cytology needle into the lesion in nominal doses of 250-500 mg." | 1.40 | Bronchoscopic intratumoral injection of tranexamic acid to prevent excessive bleeding during multiple forceps biopsies of lesions with a high risk of bleeding: a prospective case series. ( Zamani, A, 2014) |
"To determine whether radiation combined with Trans-4-AminoMethyl Cyclohexane carboxylic Acid (AMCA, or tranexamic acid, Cyklokapron) results in a better tumor response than radiation alone." | 1.32 | Response of rat prostate and lung tumors to ionizing radiation combined with the angiogenesis inhibitor AMCA. ( Gebbink, MF; Kal, HB; Struikmans, H; Voest, EE, 2004) |
Research
Studies (10)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (50.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Zamani, A | 1 |
Schwameis, M | 1 |
Thaler, J | 1 |
Schober, A | 1 |
Schörgenhofer, C | 1 |
Kulinna-Cosentini, C | 1 |
Laggner, A | 1 |
Röggla, M | 1 |
Jilma, B | 1 |
Huang, GC | 1 |
Chen, LJ | 1 |
Liu, HC | 1 |
Chen, YJ | 1 |
Kal, HB | 1 |
Struikmans, H | 1 |
Gebbink, MF | 1 |
Voest, EE | 1 |
Tanaka, N | 2 |
Ogawa, H | 2 |
Kinjo, M | 2 |
Kohga, S | 2 |
Tanaka, K | 3 |
Kodama, Y | 1 |
Astedt, B | 1 |
Tropé, C | 1 |
Meijer, K | 1 |
Smid, WM | 1 |
Geerards, S | 1 |
van der Meer, J | 1 |
Serdengeçti, S | 1 |
Büyükünal, E | 1 |
Molinas, N | 1 |
Demirelli, FH | 1 |
Berkarda, N | 1 |
Eyüboğlu, H | 1 |
Derman, U | 1 |
Berkarda, B | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Prophylactic Topical Epinephrine to Reduce Transbronchial Lung Biopsy-related Hemorrhage in Lung Transplant Recipients: a Prospective Double-blind Placebo-controlled Trial (PROPHylactic Epinephrine in Transbronchial Biopsy [PROPHET] Trial)[NCT03126968] | Phase 2/Phase 3 | 100 participants (Actual) | Interventional | 2017-07-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
10 other studies available for tranexamic acid and Lung Neoplasms
Article | Year |
---|---|
Bronchoscopic intratumoral injection of tranexamic acid to prevent excessive bleeding during multiple forceps biopsies of lesions with a high risk of bleeding: a prospective case series.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bronchoscopy; Epinephrine; Female; Hemorrhage; Humans; Injec | 2014 |
Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings.
Topics: Adenocarcinoma; Aged; Anemia; Antifibrinolytic Agents; Antineoplastic Combined Chemotherapy Protocol | 2014 |
Development of vitreous haemorrhage during treatment with bevacizumab for metastatic rectal cancer.
Topics: Adenocarcinoma; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Human | 2008 |
Response of rat prostate and lung tumors to ionizing radiation combined with the angiogenesis inhibitor AMCA.
Topics: Angiogenesis Inhibitors; Animals; Antifibrinolytic Agents; Cell Line, Tumor; Chemotherapy, Adjuvant; | 2004 |
Ultrastructural study of the effects of tranexamic acid and urokinase on metastasis of Lewis lung carcinoma.
Topics: Animals; Blood Platelets; Cyclohexanecarboxylic Acids; Endopeptidases; Fibrin; Lung Neoplasms; Male; | 1982 |
Effects of tranexamic acid and urokinase on hematogenous metastases of Lewis lung carcinoma in mice.
Topics: Animals; Cyclohexanecarboxylic Acids; Female; Fibrin; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL | 1981 |
Effect of tranexamic acid on the growth and metastasis of V2 carcinoma in rabbits.
Topics: Animals; Carcinoma; Cyclohexanecarboxylic Acids; Fibrin; Fibrinolysis; Lung Neoplasms; Lymphatic Met | 1981 |
Effect of tranexamic acid on progress of experimental tumours and on DNA-synthesis.
Topics: Adenocarcinoma; Animals; Cyclohexanecarboxylic Acids; DNA, Neoplasm; Liver Neoplasms, Experimental; | 1980 |
Hyperfibrinogenolysis in disseminated adenocarcinoma.
Topics: Adenocarcinoma; Adult; Afibrinogenemia; alpha-2-Antiplasmin; Antifibrinolytic Agents; Brain Ischemia | 1998 |
Overall survival results of non-small cell lung cancer patients: chemotherapy alone versus chemotherapy with combined immunomodulation.
Topics: Adjuvants, Immunologic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; L | 1988 |